← Back to home
Comparison · Analytics

ApexCharts vs pharmaverseadam

A side-by-side editorial comparison of ApexCharts and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.

ApexCharts vs pharmaverseadam: at a glance

FeatureApexChartspharmaverseadam
SectorAnalyticsAnalytics
Velocity score10.00.0
Sparks · 30d30
Top themescharting, raw-data-input, chart-morphing, premium-tieringpharmaverse, clinical-data, adam, test-data
Last editorial update1d ago4d ago
WebsiteVisit →Visit →

What is ApexCharts?

Licensing settled, ApexCharts is back to changing what a chart can take as input.

ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.

Read the full ApexCharts trajectory →

What is pharmaverseadam?

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

Read the full pharmaverseadam trajectory →

ApexCharts vs pharmaverseadam: editorial side-by-side

A
ApexCharts
ANALYTICS
10.0

Licensing settled, ApexCharts is back to changing what a chart can take as input.

◆ Current state

ApexCharts is deep into a fast v6 line, shipping roughly weekly. The licensing arc that dominated 6.5 through 6.7 — trial watermarks, the first premium-gated chart type, then entitlement checks — has settled, and the last three releases are library work again. 6.9.0 is the largest of them: a histogram type that bins raw samples, a morph engine that conserves marks across chart types, and the end of the library's dependency-free packaging.

◆ Where it's heading

The through-line now is input and arrangement rather than catalogue size. Charts increasingly accept the measurements a team actually has instead of pre-aggregated values, and the seams that let you hand a chart its own layout — plotOptions.unit.positions, the pluggable layout hook — are being filled in with kits rather than hard-coded options. The premium boundary has stopped moving; the free catalogue keeps growing around it.

◆ Prediction

Expect the raw-observation pattern to reach another chart type now that the bar pathway handles binning, and expect the remaining pluggable seams to get companion kits the way positions just did.

P0.0

pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.

◆ Current state

pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.

◆ Where it's heading

Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.

◆ Prediction

Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.

Alternatives to ApexCharts and pharmaverseadam

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ApexCharts or pharmaverseadam.

See all ApexCharts alternatives → · See all pharmaverseadam alternatives →

Recent activity from ApexCharts and pharmaverseadam

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1d agoApexChartsUnit charts get a 39-shape companion kit
  2. 2d agoApexChartsHistogram bins raw samples; charts morph between types
  3. 9d agoApexChartsPer-data-point label offsets land as functions
  4. 10d agoApexChartsPie and donut slice clicks work again after a 6.7.0 regression
  5. 16d agoApexChartsSunburst charts arrive; premium features now need an entitled plan
  6. 22d agoApexChartsUnit chart is the first premium-gated chart type
  7. 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
  8. 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
  9. 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
  10. 2y agopharmaverseadam1.0 declares the dataset collection stable
  11. 2y agopharmaverseadamFirst release of the ADaM dataset collection

Frequently asked questions

What is the difference between ApexCharts and pharmaverseadam?

They serve adjacent needs but don't currently overlap on shipped themes. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 0.0), with 3 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is ApexCharts better than pharmaverseadam?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. ApexCharts is currently shipping more aggressively (velocity 10.0 vs 0.0), with 3 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to ApexCharts?

Top ApexCharts alternatives in Analytics are ranked by recent ship velocity. Browse the "ApexCharts alternatives" section above for the current picks, or visit /alternatives/apexcharts for the full list with editorial commentary on each.

What are the best alternatives to pharmaverseadam?

Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.